German ZEW: A first glimpse of the consequences of the second nationwide lockdown German ZEW: A first glimpse of the consequences of the second nationwide lockdown German ZEW: A first glimpse of the consequences of the second nationwide lockdown

German ZEW: A first glimpse of the consequences of the second nationwide lockdown

Macro
Christopher Dembik

Head of Macroeconomic Research

Summary:  The German November ZEW Survey is at the top of the economic calendar today, but it did not really drive market sentiment as investors are still focusing on Pfizer vaccine news and hopes of swifter economic recovery in 2021.


Today’s German November ZEW report is one of the most important data set released this week. It gives us a first glimpse of the consequences of the second nationwide lockdown on economic expectations. Aligned with consensus, all the main components of the survey for November are declining, reflecting the impact of the new partial lockdown or light lockdown decided by the German government to contain the second wave of the virus. The current situation assessment is deteriorating again, sliding 4.8 points to land at minus 64.3 versus expected at minus 65. Without much surprise, many panelist mentioned as a key concern the economic uncertainty related to the virus and the poor financial situation of the banking sector and insurers due to the low growth and low interest rates environment and risks of rising non-performing loans in coming months. This is not really new, but it will certainly continue to weight on the panelists’ mood in the coming months as long as there is no better economic visibility.

Looking into details, there are clear indications in the report that the German economy is once again edging closer to recession territory. Economic expectations, which are the most watched components of the report, are edging down again. In November, the subindex recorded a massive drop of 19.5 points to 32.8, but it is still standing way above its long-term average of 19.5. Unlike what has happened during the previous lockdown that occurred last Spring, we don’t see a general decline in economic sentiment across all the sectors. Firms most exposed to the new restrictions (mostly in the services sector and in the construction sector) are experiencing a new deterioration in economic sentiment. The subindex for the services sector is down at 21.8 vs prior at 26.7 and the subindex for the construction sector is also falling, at 14.3 vs prior at 16.6. In contrast, all the other sectors are going through stabilization (such as the utilities sector) or are heading north (automobile, mechanical engineering and chemicals/pharmaceuticals). This gap in economic sentiment is not only indicating that some firms are less hit by restrictions than in the first lockdown but also that higher foreign demand, especially from Asia/China, is fueling increased optimism in the German manufacturing sector. It thus confirms that economic contraction in Q4 will be less important than in Q2 as business continues more or less as normal in the manufacturing sector.

There is light at the end of the tunnel. The survey has been conducted before Pfizer and BioNTech announced vaccine candidate against COVID-19 achieved success in first interim analysis from Phase 3 study yesterday. It was undoubtedly positive and unexpected news, though it is still too early at that stage to know the exact implications of these announcements. There are still a lot of pending questions such as whether the vaccine will prevent transmission of COVID-19 or how many doses will be necessary etc. That being said, the increased likelihood of an imminent vaccine might have positive trigger effects on consumers and some firms. Most of the economic damage related to the pandemic mostly results from the fear of the virus, not the virus itself. Therefore, if there is credible hope of economic normalization in 2021, perhaps in the first semester, we can expect to see in coming months an improvement in sentiment survey, including in the ZEW survey. Most firms that are currently going through turmoil, typically hairdressers, will get a decisive boost from the vaccine and will be able to see demand going back to normal almost immediately afterwards. That’s why we should not overstate the impact of today’s ZEW report and, in that sense, the market was certainly right not to pay too much attention to it.

Disclaimer

The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer)

Saxo Markets
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo Markets is a registered Trading Name of Saxo Capital Markets UK Ltd (‘SCML’). SCML is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo Markets assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992